Lost in translation? The pursuit of lung-protective ventilation by Jones, Andrew T
Page 1 of 3
(page number not for citation purposes)
Available online http://ccforum.com/content/12/2/122
Abstract
Acute lung injury (ALI) and the acute respiratory distress syndrome
(ARDS) remain important causes of morbidity and mortality in the
critically ill patient, with far-reaching short-term and long-term
implications for individual patients and for healthcare providers. It is
well accepted that mechanical ventilation can worsen lung injury,
potentially worsening systemic organ function, and can thus impact
on mortality in acute lung injury (ALI)/ARDS. Unfortunately,
although the concept of minimizing such damage via lung-
protective ventilatory strategies is widely acknowledged, effective
integration of such an approach into clinical practice remains more
elusive. The study by the Irish Critical Care Trials Group published
in the previous edition of Critical Care describes a 10-week real-
life survey of all intensive care unit admissions across Ireland,
detailing for the first time the epidemiology of ALI/ARDS in this
population and clinician’s attempts to deliver lung-protective
ventilation. The authors also report hypothesis-generating data on
the implications of statin use in this population. The present
commentary reviews aspects of this work, with particular attention
to the implementation of low-tidal-volume/lung-protective ventilatory
strategies in ALI/ARDS.
Firstly, my congratulations to those at the Irish Critical Care
Trials Group on their paper detailing the epidemiology and
ventilatory management of ALI/ARDS across Ireland [1]; the
first publication from this recently established clinical
research group. The authors also report hypothesis-genera-
ting data on the implications of statin use in this population.
The present commentary reviews aspects of this work, with
particular attention to the implementation of low-tidal-
volume/lung-protective ventilatory strategies in ALI/ARDS.
The advantages of multicenter collaborative research are
clear to all, but does the influence of such groups extend
beyond the individual studies undertaken? Although
individual organizations often have differing infrastructures
and approaches to study development, planning and funding,
they invariably share a cohesive spirit and a mission to
improve the care and outcomes of those with critical illness
[2]. As a result, they surely provide fertile environments not
only for ongoing education and training in critical care
medicine and research methodology, but also a forum for the
discussion and advancement of clinical critical care practice.
The data regarding statin use are tantalizing, and add to the
growing debate and interest regarding these agents in the
critically ill patient [3]. As the authors rightly conclude, the
small numbers involved and the modest data collection in this
field, require that these data be considered hypothesis
generating – albeit in conjunction with existing data –
supportive of further study and potentially, a therapeutic trial.
The incidence of ALI/ARDS in the study by the Irish Critical
Care Trials Group, 27% of those patients receiving
mechanical ventilation (19% of all intensive care unit
admissions), is comparable with the literature from recent
large surveys from both Europe and North America [4,5]. The
mortality figures, albeit only the intensive care unit mortality is
quoted, seem favourable in comparison with historical data in
Europe. Such figures alone, however, require the provision of
significant healthcare resources in terms of hospital and
critical care services, and the figures mask, or at best make
no reference to, the longer-term morbidity attributable to this
condition, with its significant direct and indirect healthcare,
social and personal costs [4,6]. Acknowledging this burden
of disease, the authors rightly identify the importance of
accurate, up-to-date epidemiological data to inform the
design and feasibility of future clinical trials.
Amongst the physiological data presented, the Irish Critical
Care Trials Group report no association of the tidal volume or
plateau pressure with mortality. Cognizant of some deficien-
cies in their data collection, they suggest that this is at least
in part due to ‘relatively good adherence to lung protective
ventilation’ [1], reasoning that only 5% of patients received a
tidal volume >12 ml/kg predicted body weight (PBW) and
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only 12% of patients received a plateau pressure
>30 cmH2O. The mean tidal volume was ~8.4 ml/kg PBW,
however, suggesting that a significant number of patients
received higher tidal volumes than the accepted upper limit of
a low-tidal-volume approach in the Acute Respiratory Distress
Syndrome Network ARMA study (8 ml/kg PBW) [7]. Is this
truly lung protective, or is this just as far as clinicians were
prepared to go? Whatever the answer, the Irish Critical Care
Trials Group are not alone [8].
The publication of the Acute Respiratory Distress Syndrome
Network (ARDSNet) ARMA study in 2000, with its 22%
relative reduction in mortality with low-tidal-volume ventilation
in patients with ALI/ARDS, was generally heralded as a
landmark advance in the care of the critically ill patient.
Subsequent uptake of this approach, however, has been
disappointingly slow [9].
Poor translation of research into clinical practice is not a
problem specific to critical care, or indeed to lung protective
ventilation, with potential causes and solutions well docu-
mented [10]. Furthermore, even where clinicians are willing,
significant organizational and clinical barriers exist in imple-
menting what is a complex, multidisciplinary process at the
bedside [11]. Translation of evidence to clinical practice may
be improved by the adoption of protocols to drive clinical
care, although, this may not be as simple as it might first
appear. But what of the subsequent concerns voiced about
the study design and the aspects of patient safety?
The ARMA study was criticized for comparing two extremes
of ventilatory practice (6 ml/kg PBW versus 12 ml/kg PBW)
rather than employing more common and potentially safer
practice as a control (8 to 10 ml/kg). Critics argued that as a
result participants were subjected to higher risks, and that the
investigators were led to erroneously conclude that venti-
lation with the lowest tidal volumes is superior [12]. In
response, the ARDSNet investigators challenged the metho-
dology of their critic’s meta-analysis and reiterated their belief
that, at the time the study was instigated, no such standard of
ventilatory care existed [13]. In addition, they subsequently
reported further data from the ARMA study, detailing benefits
of tidal volume and plateau pressure reduction across the
range of disease severity and baseline plateau pressures,
arguing against the U-shaped relationship for tidal volume
and mortality alluded to by their critics [13,14]. As the reader
is undoubtedly aware, the subsequent repercussions from
these events have been significant [15,16], and robust
debate continues [14,17,18]. It seems highly probable that
this perceived uncertainty has impacted on the degree to
which low-tidal-volume ventilation has been pursued by
practicing clinicians.
Where do we go from here? Clinical education and process
management undoubtedly have a role to play, but at what
target are clinicians aiming? On reading the current article by
the Irish Critical Care Trials Group, some will suggest that,
although there has been improvement, there is some way to
go before we achieve the evidence-based standard of
ventilatory practice in ALI/ARDS. Others, meanwhile, will
argue that – based on existing evidence – we may be close
to arriving at that standard, and to go lower requires further
investigation. Under such circumstances, it would not be
surprising if we see relatively little change in the delivered
tidal volume in the near future.
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